Synthesis, X-ray structure, and spectroscopic investigation of new Co(II)/Cd(II) complexes formed via the reaction of 1-hydroxymethyl-3,5-dimethylpyrazole and Co0, CdCl2, NH4I

Cationic-anionic complexes of Cu(II) and Co(II) with N-scorpionate ligand - structure, spectroscopy, and catecholase activity

We report structural and physicochemical characterization supported by quantum chemical studies of two novel copper(II) [CuLCl]2[CuCl4] (1) and cobalt(II) [CoLCl][CoL'Cl3] (2) cationic-anionic complexes with N-scorpionate type ligand, N,N,N-tris(3,5-dimethylpyrazol-1-ylmethyl)amine (L), where L' is 1-methylamine-3,5-dimethylpyrazole. The obtained complexes are the first reported examples of cationic-anionic coordination compounds tested for catecholase activity. Interestingly, only copper complex (1) shows catalytic activity in the oxidation of 3,5-di-tert-butylcatechol (3,5-DTBC), which turned out to be solvent dependent. Here, experimental UV-vis spectroscopy of 1 shows that essential features of the solid-state spectrum are maintained in DMSO and MeOH solvents. In contrast, the build-up of a new feature around 465 nm for 1 in CH3CN was noted, along with negligible activity. According to quantum chemical calculations, this feature could be attributed to ligand-to-metal excitations within the [CuCl4]2- fragment disturbed by adjacent [CuLCl]+ species. The band shifts to lower energies compared to solid-state measurements as the two charged fragments get closer due to Coulomb interactions. In DMSO, the solvent molecule serves as an inert ligand in a [CuLCl]+ fragment and blocks the catalytic center, disturbing the formation of the [catalyst-substrate] complex and decreasing activity, while in MeOH, the solvent effectively stabilizes [CuCl4]2-via a H-bond network and the free coordination site is accessible, thus allowing a substrate molecule to bind. The critical advantage of the investigated complexes, in the context of their possible catalytic activity, was the fact that their usage would not introduce any unnecessary counterions.

Selective Cytotoxicity of Complexes with N,N,N-Donor Dipodal Ligand in Tumor Cells

The present article demonstrates selective cytotoxicity against cancer cells of the complexes [Co(L^D)₂]I₂∙CH₃OH (1), [CoL^D(NCS)₂] (2) and [VOL^D(NCS)₂]∙C₆H₅CH₃ (3) containing the dipodal tridentate ligand LD = N,N-bis(3,5-dimethylpyrazol-1-ylmethyl)amine), formed in situ. All tested complexes expressed greater anticancer activities and were less toxic towards noncancerous cells than cisplatin. Cobalt complexes (1 and 2) combined high cytotoxicity with selectivity towards cancer cells and caused massive tumour cell death. The vanadium complex (3) induced apoptosis specifically in cancer cells and targeted proteins, controlling their invasive and metastatic properties. The presented experimental data and computational prediction of drug ability of coordination compounds may be helpful for designing novel and less toxic metal-based anticancer species with high specificities towards tumour cells.

A family of complexes with N-scorpionate-type and other N-donor ligands obtained in situ from pyrazole derivative and zerovalent cobalt. Physicochemical and cytotoxicity studies

In this paper we described one pot synthetic pathways which generated in situ three complexes which contain three different ligands: N,N,N-tris(3,5-dimethylpyrazolylmethyl)amine (L¹), urotropine (L²) and 3,5-dimethylpyrazole (L³).

New oxovanadium(iv) complexes with pincer ligand obtained in situ: experimental and theoretical studies on the structure, spectroscopic properties and antitumour activity

Experimental and theoretical studies on the structure and spectroscopic properties of two complexes: [VOL¹(NCS)₂] (1) and [VOL¹(NCS)₂]·C₆H₅CH₃ (2) where L¹-N,N-bis(3,5-dimethylpyrazol-1-ylmethyl)amine have been reported.

Assembling novel Cd(II) complexes with multidentate nitrogen donor ligands obtained in situ from the system: zerovalent copper, cadmium oxide, 1-hydroxymethyl-3,5-dimethylpyrazole and ammonium thiocyanate

A novel 3D coordination polymer [Cd2(L(1))(2)(SCN)(4)(MeOH)(2)](n) (1) and monomeric [Cd(NCS)(2)L(2)] (2) (L(1) = urotropine, L(2) = tris(1-(3,5-dimethylpyrazolylmethyl))amine) have been prepared in a one-pot synthesis using 1-hydroxymethyl-3,5-dimethylpyrazole as the starting ligand. The most prominent feature is the formation in situ of the organic compounds: urotropine and scorpionate-tripodal ligands.